Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Traffic (Copenhagen, Denmark)
|
April 14, 2017
Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease
Georg F Vogel, Andreas R Janecke, Iris M Krainer, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 19, 2010
Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease
D C Wilson, A G Thomas, N M Croft, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2018
Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort
Neil Chanchlani, Kajal Mortier, Linda J Williams, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 23, 2018
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response
Victoria M Merrick, Kajal Mortier, Linda J Williams, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Traffic (Copenhagen, Denmark)
|
April 14, 2017
Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease
Georg F Vogel, Andreas R Janecke, Iris M Krainer, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 19, 2010
Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease
D C Wilson, A G Thomas, N M Croft, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2018
Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort
Neil Chanchlani, Kajal Mortier, Linda J Williams, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 23, 2018
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response
Victoria M Merrick, Kajal Mortier, Linda J Williams, et al.
Page
of 3